BioSpace News Archive

Data Operating System provides actionable insights to improve outcomes and reduce costs

Grant supports translational research for hepcidin mimetic PTG-300 for potential treatment of rare blood disorders

Nearly 100 percent of chief medical information officers (CMIOs) in U.S. hospitals believe medication management improvement initiatives are having a positive impact and that patient safety issues are less likely to occur today, as compared to 5 years ago, according to a new survey from the Association of Medical Directors of Information Systems (AMDIS)

Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the third quarter of 2018 on Thursday, October 25, 2018. During a conference call at 10:30 a.m. EDT on October 25,

Ms. Myers has more than fourteen years of experience designing, launching, marketing, and selling healthcare solutions.

Former SVP and Global R&D Head at Roche brings drug development experience as Rheos product engine generates medicines for immune-mediated diseases

Phase I/II Trial to Investigate Combination Therapy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma to take place at Dana-Farber Cancer Institute

Nucleix Ltd., a leading cancer detection company, announced today positive results from a clinical study designed to evaluate its innovative Lung EpiCheck™, a blood test for early detection of lung cancer.

Dietmar Siemssen (55) will join the Management Board of Gerresheimer AG as Chief Executive Officer on November 1, 2018.

Gibson Oncology, LLC (“Gibson”), a privately held clinical stage company, acquired three (3) clinical non-camptothecin Topoisomerase I drugs from Linus Oncology.